Aspirin in Primary and Secondary Prevention in Elderly Adults Revisited

被引：3
作者：
Wilson, Ryan [1 ]
Gazzala, Jawahar [1 ]
House, Jeff [1 ]
机构：
[1] Univ Florida, Dept Med, Coll Med, Jacksonville, FL 32209 USA
来源：
SOUTHERN MEDICAL JOURNAL | 2012年 / 105卷 / 02期
关键词：
aspirin; elderly; geriatric; primary prevention; secondary prevention; LOW-DOSE ASPIRIN; CARDIOVASCULAR EVENTS; TRIAL; METAANALYSIS; DISEASE; PEOPLE;
D O I：
10.1097/SMJ.0b013e3182426eef
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Despite the frequency and long duration of aspirin use, its role in primary and secondary prevention in older adults is not well studied. This review takes a critical look at the available literature on aspirin efficacy in elderly adults, and some relevant guidelines for practicing physicians are suggested.
引用
收藏
页码：82 / 86
页数：5
相关论文
共 30 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]   Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin [J].
Bartolucci, Alfred A. ;
Howard, George .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (06) :746-750
[4]   The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease [J].
Belch, Jill ;
MacCuish, Angus ;
Campbell, Iain ;
Cobbe, Stuart ;
Taylor, Roy ;
Prescott, Robin ;
Lee, Robert ;
Bancroft, Jean ;
MacEwan, Shirley ;
Shepherd, James ;
Macfarlane, Peter ;
Morris, Andrew ;
Jung, Roland ;
Kelly, Christopher ;
Connacher, Alan ;
Peden, Norman ;
Jamieson, Andrew ;
Matthews, David ;
Leese, Graeme ;
McKnight, John ;
O'Brien, Iain ;
Semple, Colin ;
Petrie, John ;
Gordon, Derek ;
Pringle, Stuart ;
MacWalter, Ron .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 :a1840
[5]   Aspirin for the primary prevention of cardiovascular events in women and men - A sex-specific meta-analysis of randomized controlled trials [J].
Berger, JS ;
Roncaglioni, MC ;
Avanzini, F ;
Pangrazzi, I ;
Tognoni, G ;
Brown, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (03) :306-313
[6]   Secondary prevention of coronary heart disease in the elderly [J].
Bulpitt, CJ .
HEART, 2005, 91 (03) :396-400
[7]  
Caplan LR, 2010, CLIN DIAGNOSIS STROK
[8]   Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen [J].
Chan, FKL ;
Chung, SCS ;
Suen, BY ;
Lee, YT ;
Leung, WK ;
Leung, VKS ;
Wu, JCY ;
Lau, JYW ;
Hui, Y ;
Lai, MS ;
Chan, HLY ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) :967-973
[9]  
De Berardis G, 2009, BMJ, P339
[10]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
123